Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Nov 30, 2010

Premium

Aushon BioSystems has appointed Sven Beushausen to be its new chief scientific officer. He joins the Billerica, Mass.-based microarray technologies firm from Pfizer, where he served as molecular medicine site leader. Beushausen also has held other senior scientific positions within Pfizer, and previously served as director of manufacturing technologies for Invitrogen (now Life Technologies).


Adesto Technologies has appointed Nelson Chan to its board of directors. Chan was previously the CEO of Magellan Navigation and the executive vice president and general manager of consumer business at SanDisk. He currently serves on the board of directors of Affymetrix, Bridgelux, Nanosys, and Synaptics.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.